JP5619016B2 - 重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット - Google Patents

重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット Download PDF

Info

Publication number
JP5619016B2
JP5619016B2 JP2011533853A JP2011533853A JP5619016B2 JP 5619016 B2 JP5619016 B2 JP 5619016B2 JP 2011533853 A JP2011533853 A JP 2011533853A JP 2011533853 A JP2011533853 A JP 2011533853A JP 5619016 B2 JP5619016 B2 JP 5619016B2
Authority
JP
Japan
Prior art keywords
complex
level
patient
septic shock
patients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2011533853A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012507030A5 (enExample
JP2012507030A (ja
Inventor
ド ラ ガランデリエ，ディディエ パエン
ド ラ ガランデリエ，ディディエ パエン
ルカシェウィッツ，アン−クレア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique - Hôpitaux de Paris
Original Assignee
Assistance Publique - Hôpitaux de Paris
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US12/259,596 external-priority patent/US8283131B2/en
Application filed by Assistance Publique - Hôpitaux de Paris filed Critical Assistance Publique - Hôpitaux de Paris
Publication of JP2012507030A publication Critical patent/JP2012507030A/ja
Publication of JP2012507030A5 publication Critical patent/JP2012507030A5/ja
Application granted granted Critical
Publication of JP5619016B2 publication Critical patent/JP5619016B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Physiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2011533853A 2008-10-28 2009-10-27 重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット Expired - Fee Related JP5619016B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US12/259,596 US8283131B2 (en) 2008-10-28 2008-10-28 Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock
US12/259,596 2008-10-28
US15852009P 2009-03-09 2009-03-09
US61/158,520 2009-03-09
PCT/IB2009/007493 WO2010049818A1 (en) 2008-10-28 2009-10-27 Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock

Publications (3)

Publication Number Publication Date
JP2012507030A JP2012507030A (ja) 2012-03-22
JP2012507030A5 JP2012507030A5 (enExample) 2012-11-29
JP5619016B2 true JP5619016B2 (ja) 2014-11-05

Family

ID=41572522

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533853A Expired - Fee Related JP5619016B2 (ja) 2008-10-28 2009-10-27 重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット

Country Status (5)

Country Link
US (1) US20110287433A1 (enExample)
EP (1) EP2350646B1 (enExample)
JP (1) JP5619016B2 (enExample)
CN (1) CN102257387A (enExample)
WO (1) WO2010049818A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2379752B1 (fr) * 2009-01-19 2015-09-30 Biomérieux S.A. Procedes pour determiner la susceptibilite a contracter une infection nosocomiale chez un patient et pour etablir un pronostic d'evolution d'un syndrome septique
ES2899007T3 (es) * 2011-01-21 2022-03-09 Inst Nat Sante Rech Med Métodos para predecir el riesgo de insuficiencia respiratoria en un paciente séptico al medir niveles reducidos de endocan en sangre
FR2970975B1 (fr) 2011-01-27 2016-11-04 Biomerieux Sa Procede et kit pour determiner in vitro le statut immunitaire d'un individu
CN102636645A (zh) * 2012-04-24 2012-08-15 广州吉赛生物科技有限公司 一种sTERM-1酶联免疫检测试剂盒及其方法
WO2015077781A1 (en) 2013-11-25 2015-05-28 Children's Hospital Medical Center Temporal pediatric sepsis biomarker risk model
CA2942577A1 (en) * 2014-03-14 2015-09-17 Robert E. W. Hancock Diagnostic for sepsis
KR101929772B1 (ko) * 2016-11-02 2018-12-17 연세대학교 산학협력단 패혈증 진단을 위한 정보를 제공하는 방법 및 이를 이용한 키트
CN108982844B (zh) * 2018-08-17 2021-09-24 北京市心肺血管疾病研究所 血清S100a8/9复合体水平在急性心肌梗死诊断及预后判断中的应用
WO2021207365A1 (en) * 2020-04-07 2021-10-14 The Wistar Institute Of Anatomy And Biology Reawakening of dormant tumor cells by modified lipids derived from stress activated neutrophils
US20240230674A1 (en) * 2021-04-30 2024-07-11 Roche Diagnostics Operations, Inc. Strem1 marker panels for early detection of sepsis
CN114606308A (zh) * 2022-01-26 2022-06-10 江门市中心医院 脓毒症ards的预后与治疗标志物
CN116298318A (zh) * 2023-03-20 2023-06-23 复旦大学附属中山医院 一种脓毒症患者围术期器官功能障碍的诊断试剂盒
CN118717994A (zh) * 2024-07-26 2024-10-01 浙江大学医学院附属第一医院(浙江省第一医院) 肝硬化中S100A8/A9诱导NK细胞产生IFNγ的应用
CN119492874A (zh) * 2024-10-30 2025-02-21 首都医科大学附属北京儿童医院保定医院 S100a8/a9在评估感染性疾病病情严重程度中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1297922A (zh) * 1999-11-26 2001-06-06 上海博道基因技术有限公司 一种多肽－人钙结合s100蛋白21和编码该多肽的多核苷酸
DE50108027D1 (de) * 2001-12-04 2005-12-15 Brahms Ag Verwendung der Glycin-N-Acyl-Transferase (GNAT) für die Diagnose von Entzündungserkrankungen und Sepsis
EP1562984B1 (de) * 2002-11-20 2006-08-09 B.R.A.H.M.S Aktiengesellschaft Sandwich-immunoassay zur bestimmung von proanp-teilpeptiden
CN1897959A (zh) * 2003-09-29 2007-01-17 沃伦药品公司 用于治疗和预防脓毒病和粘连形成的组织保护细胞因子
TR200700896T1 (tr) * 2004-07-23 2007-04-24 Aspenbio, Inc. Apandisit teşhisine ilişkin yöntem ve cihazlar
US7659087B2 (en) * 2004-07-23 2010-02-09 Aspenbio Pharma, Inc. Methods and devices for diagnosis of appendicitis
CN101193622A (zh) * 2005-06-09 2008-06-04 比奥里波克斯公司 治疗炎性疾病的方法和组合物
CA2624569A1 (en) * 2005-10-03 2007-04-12 Biosite Incorporated Methods and compositions for diagnosis and/or prognosis in systemic inflammatory response syndromes
EP1950310A1 (en) * 2007-01-23 2008-07-30 Charite-Universitätsmedizin Berlin Method for risk prediction of a postoperative sepsis in a human
DE102007009751A1 (de) * 2007-02-28 2008-09-04 B.R.A.H.M.S Aktiengesellschaft Verfahren zur selektiven Bestimmung von Procalcitonin 1-116 für diagnostische Zwecke sowie Antikörper und Kits zur Durchführung eines solchen Verfahrens
EP2085486A1 (en) * 2008-02-01 2009-08-05 Assistance Publique - Hopitaux de Paris Methods and kits for the rapid determination of patients at high risk of death during septic shock
US8283131B2 (en) * 2008-10-28 2012-10-09 Assistance Publique-Hopitaux De Paris Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock

Also Published As

Publication number Publication date
WO2010049818A1 (en) 2010-05-06
CN102257387A (zh) 2011-11-23
EP2350646A1 (en) 2011-08-03
EP2350646B1 (en) 2016-01-13
US20110287433A1 (en) 2011-11-24
JP2012507030A (ja) 2012-03-22

Similar Documents

Publication Publication Date Title
JP2012507030A (ja) 重症敗血症及び敗血症性ショック中の死亡の危険性が高い患者を迅速に決定するための方法及びキット
Diamant et al. Toward clinically applicable biomarkers for asthma: an EAACI position paper
JP2017500562A (ja) アルツハイマー病に関するバイオマーカー及び方法
JP2025019061A (ja) 術後有害事象の診断または予後
JP7544879B2 (ja) 重篤患者用の療法モニタリングマーカーとしてのｐｒｏ－ａｄｍ
WO2009114532A2 (en) Markers for diagnosis of pulmonary inflammation and methods related thereto
US20200341011A1 (en) Astrocyte exosome complement-based assay for neuroinflammation in alzheimer's disease and uses thereof
RU2672595C2 (ru) Способ диагностики молекулярного фенотипа пациента, страдающего заболеванием, сопровождающимся хроническими воспалениями
JP2023095851A (ja) 抗生物質治療をモニタリングするためのマーカーとしてのｐｃｔおよびｐｒｏ－ａｄｍ
US8283131B2 (en) Methods and kits for the rapid determination of patients at high risk of death during severe sepsis and septic shock
US20230333121A1 (en) Methods and compositions relating to biomarkers for neurodegenerative diseases
WO2020016888A9 (en) Determining responders to inflammation treatment
US20160244835A1 (en) Urinary neuropilin-1 (nrp-1) as a prognostic marker for nephritis and lupus nephritis
WO2019117132A1 (ja) がん免疫療法の予後予測のためのバイオマーカー
Matboli et al. Evaluation of urinary autophagy transcripts expression in diabetic kidney disease
EP1850130B1 (en) Gene markers and utilzation of the same
KR20240031236A (ko) 무증상 거부반응의 비-침습적 진단
RU2788885C2 (ru) Прокальцитонин и про-адм в качестве маркеров для мониторинга лечения антибиотиками
RU2782305C2 (ru) Про-адм в качестве маркера мониторинга терапии для критически больных пациентов
Li et al. AKT/p65-dependent upregulation of CD64 by LPS drives pathogenesis and diagnostic potential in sepsis
EP3645747A1 (en) Methods for diagnosing inflammatory phenotypes of chronic obstructive pulmonary disease
Lesur et al. Research Proven infection-related sepsis induces a differential stress response early after ICU admission

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20121011

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20121011

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20131022

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20131023

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140120

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140418

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140819

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140916

R150 Certificate of patent or registration of utility model

Ref document number: 5619016

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees